Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Long-Term Investments (2020 - 2022)

Sotera Health has reported Long-Term Investments over the past 3 years, most recently at $9.5 million for Q1 2022.

  • For Q1 2022, Long-Term Investments rose 3.5% year-over-year to $9.5 million; the TTM value through Mar 2022 reached $9.5 million, up 3.5%, while the annual FY2021 figure was $9.4 million, 30.11% down from the prior year.
  • Long-Term Investments for Q1 2022 was $9.5 million at Sotera Health, up from $9.4 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $13.5 million in Q4 2020 and troughed at $9.2 million in Q1 2021.
  • A 3-year average of $10.1 million and a median of $9.4 million in 2021 define the central range for Long-Term Investments.
  • Biggest five-year swings in Long-Term Investments: plummeted 30.11% in 2021 and later increased 3.5% in 2022.
  • Year by year, Long-Term Investments stood at $13.5 million in 2020, then plummeted by 30.11% to $9.4 million in 2021, then increased by 1.54% to $9.5 million in 2022.
  • Business Quant data shows Long-Term Investments for SHC at $9.5 million in Q1 2022, $9.4 million in Q4 2021, and $9.4 million in Q3 2021.